Alert
This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Te Pū rauemi KOWHEORI-19 COVID-19 resource hub

Support for people working in health during the COVID-19 pandemic. Find information about how you can support yourselves and others, including consumers, teams and colleagues which complements and aligns with Ministry of Health resources.

Kia āta kōwhiri Choosing Wisely

The Choosing Wisely campaign seeks to reduce harm from unnecessary and low-value tests and treatment.

Back to previous page

Alert 18: Thrombolysis for acute ischaemic stroke

14 Jun 2022

Both alteplase and tenecteplase can be used for stroke thrombolysis. This alert highlights action for all providers and issues where they have chosen to use tenecteplase. It identifies the need to differentiate clearly between the different dosages when using tenecteplase thrombolysis to treat acute ischaemic stroke or myocardial infarction. Serious errors, including fatalities, have occurred when there is confusion between thrombolytic medicine or dosages.


Published: 14 Jun 2022 Modified: 14 Jun 2022